Impact of the 2023 FIGO staging on a high-risk endometrial cancer cohort
2024 · Gynecologic Oncology · 0 citations
https://doi.org/10.1016/j.ygyno.2024.07.520
M
Madeline Bright
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Madeline Bright is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat